• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • Instagram
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • What is ALS/MND
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights of People with ALS/MND and Caregivers
    • Research
      • Open Science
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
      • Open Label Extension
    • Advocacy
      • Advocacy Toolkit
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
    • Drugs in Development
      • AB Science – Masitinib
      • Amylyx – AMX0035
      • Biogen – Tofersen
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Orphazyme – Arimoclomol
      • T Regulatory Cell Therapies
    • Approved Drugs
      • Radicava/Edaravone
      • Neudexta
      • Riluzole/Tiglutik
  • Support for Health Professionals
    • How to Break the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Alliance Webinars
    • Alliance Meeting
    • Allied Professionals Forum
    • ALS/MND Connect
    • Global Day
    • March of Faces
    • International Symposium on ALS/MND
  • About
    • Who We Are
    • Board of Directors
    • Committees/Advisory Councils
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Innovation and Technology Council
      • Governance Committee
      • Budget and Finance Committee
    • Staff
    • History
    • Archives
      • Newsletters
      • Meetings
    • Awards
      • Student Award Nomination
      • Forbes Norris Award Nomination
      • Humanitarian Award Nomination
      • Allied Health Professional Award Nomination
  • Members
    • Member Registration
    • Forgot Password

The ALS Association

United States of America
Date founded: 1985 through a merger of the ALS Society of America and the National ALS Foundation
Region covered:

All 50 states


Address:

1275 K Street, N.W., Suite 250
Washington, DC 20005


The ALS Association Activities

  • Funds basic scientific research directed at identifying the causes of and possible treatments and a cure for ALS. Conducts and supports two grant cycles per year.
  • Is the vital link for people with ALS and their families to information, counseling, physician referrals, in-home visits, respite care and coping with the day-to-day challenges that living with ALS presents.
  • Through its network of chapters, support groups, and ALS Association Centers, delivers care services and programs to patients, their families and caregivers at the community level.
  • Provides education and information programs and in-services training for health care professionals.
  • Hosts monthly research and care services webinars.
  • Carries out national and local public awareness and education programs through media relations and public service awareness videos to stimulate volunteerism, scientific and health care community activism, and public support essential to fight ALS.
  • Works with elected representatives to federal government, government agencies such as the National Institutes of Health and the Food and Drug Administration (FDA) and human service agencies to expand government support of research and to elicit programs to make treatments and care accessible and affordable for all ALS patients.
  • Collaborates with various research institutions, including the Northeast ALS Consortium (NEALS), ALS Therapy Alliance, The Robert Packard Center for Research at Johns Hopkins, the Centers for Disease Control (CDC), NINDS, the Muscular Dystrophy Association, and MND-UK.

The ALS Association Branches/Chapters

49 chapters and service areas, 50+ ALS clinics, Certified Center network, chapter-affiliated patient and caregiver support groups

Contacts

  • Calaneet Balas, President and CEO

Phone:

+1 202-407-8580

Fax:

+1 202-289-6801

Email:

alsinfo@alsa-national.org

Website:

www.alsa.org

Facebook:

www.facebook.com/alsassociation

Twitter:

www.twitter.com/alsassociation

YouTube:

www.youtube.com/user/thealsassociation

Primary Sidebar

Back to all

Subscribe to our Bi-Monthly Newsletter

Fill out the form below to subscribe to the Alliance’s bi-monthly newsletter, packed with updates from members associations from around the world!

Footer

Keep in touch

Sign up to receive updates and to hear what's going on in the International Alliance of ALS/MND Associations.

"*" indicates required fields

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • Instagram
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2023 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login